Functional electrical stimulation through direct 4-channel nerve stimulation to improve gait in multiple sclerosis: a feasibility study. Issue 1 (December 2015)

• Record Type: Journal Article
• Authors: Hausmann, Janet; Sweeney-Reed, Catherine; Sobieray, Uwe; Matzke, Mike; Heinze, Hans-Jochen; Voges, Jürgen; Buentjen, Lars
• Is Part Of: Journal of neuroengineering and rehabilitation. Volume 12:Issue 1(2015)
• Page Start: 1
• Page End: 9
• Publication Date: 2015-12
• Subjects: Functional electrical stimulation -- Multiple sclerosis -- Peroneal nerve -- Central drop foot -- Hemiparesis -- Rehabilitation -- Gait -- Gait improvement -- Neuroprosthetics -- Quality of life; Nervous system -- Diseases -- Patients -- Rehabilitation -- Periodicals; Nervous system -- Wounds and injuries -- Rehabilitation -- Periodicals; Biomedical engineering; 616.8043005
• DOI: 10.1186/s12984-015-0096-3
• Languages: English
• ISSNs: 1743-0003

Abstract

Abstract Background Gait dysfunction due to lower limb central paralysis, frequently involving drop foot, is a common cause of disability in multiple sclerosis and has been treated with transcutaneous functional electrical stimulation (FES). We provide here the first report of 4-channel semi-implantable FES of the peroneal nerve which has been successfully used for rehabilitation in patients following stroke. Methods FES was implemented via a 4-channel semi-implantable closed-loop system (ActiGait®, ©Ottobock), generating dorsiflexion in drop foot. Walking distance, gait symmetry (temporospatial gait analyses, Vicon Motion Systems®), gait velocity (10 m walking test) and quality of life (SF-36 questionnaire) were measured to evaluate the therapeutic benefit of this system in two patients with progressive MS. Results Walking distance increased from 517 to 1884 m in Patient 1 and from 52 to 506 m in Patient 2. Gait velocity did not change significantly in Patient 1 and increased from 0.6 to 0.8 m/s in Patient 2. Maximum deviations of center of mass from the midline to each side changed significantly after 3 months of stimulation compared to baseline, decreasing from 15 to 12 mm in Patient 1 and from 47 to 37 mm in Patient 2. Both patients experienced reduced pain and fatigue and benefits to quality of life. Adverse events did not occur during the observation period. Conclusion We conclude that implantable 4-channel FES systems are not only feasible but present a promising new alternative for treating central drop foot in MS patients.